2012 ICD-9-CM Diagnosis Code 259.4. Dwarfism, not elsewhere classified. Short description: Dwarfism NEC. ICD-9-CM 259.4 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 259.4 should only be used for claims with a date of service on or before September 30, 2015.
· ICD-9-CM Vol. 1 Diagnostic Codes. 756.4 - Chondrodystrophy. The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products: Find-A-Code Essentials. HCC Plus.
Short description: Fam hx-congen anomalies. ICD-9-CM V19.5 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, V19.5 should only be used for claims with a date of service on or before September 30, 2015.
· Version 30 Full and Abbreviated Code Titles - Effective October 1, 2012 (05/16/2012: Corrections have been made to the full code descriptions for diagnosis codes …
The 2022 edition of ICD-10-CM Q77.4 became effective on October 1, 2021.
An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, and trident hand. (mesh) ...
Q77.4 is a billable ICD code used to specify a diagnosis of achondroplasia. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Q77.4. Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. The Center for Medicare & Medicaid Services (CMS) requires medical coders to indicate whether or not a condition was present at the time of admission, in order to properly assign MS-DRG codes.
In humans, dwarfism is sometimes defined as an adult height of less than 4 feet 10 inches (58 in; 147 cm). Dwarfism can be caused by more than 300 distinct medical conditions, such that the symptoms and characteristics of individuals with dwarfism vary greatly. Disproportionate dwarfism is characterized by one or more body parts being relatively large or small in comparison to those of an average-sized adult, with growth variations in specific areas being apparent. In cases of proportionate dwarfism, the body appears normally proportioned, but is unusually small.
The ICD-10 code for “spinal anomalies NOS” is Other congenital malformations of spine – Q76.4.
Note: ICBDSR recommends using Q79.80 to identify the presence of an amniotic band. Cases with amniotic bands should be coded using the codes for the specific congenital anomalies as well as the Q79.80 amniotic band code. This anomaly will be excluded from analysis of cleft lip and palate. It is on the exclusion list as noted in WHO/CDC/ICBDSR Birth defects surveillance: a manual for programme managers ( 4 ).
The ICD-10 code for lumbosacral spina bifida with hydrocephalus is Q05.2.
Note: Although “NOS” is a valid term in the ICD-10, it should be used only when there is no possibility of obtaining a better description for a specific congenital anomaly. For cleft palate, it is uncommon to have the detailed description available (whether the soft or hard palate is affected), unless the description is provided as a result of a surgical repair.
The ICD-10 code for “frontal encephalocele” is Q01.0.
The ICD-10 code for “facial cleft” is Q18.8 (Other specified congenital malformations of face and neck).
Achondroplasia can be detected before birth by prenatal ultrasound. A DNA test can be performed before birth to detect homozygosity, wherein two copies of the mutant gene are inherited, a lethal condition leading to stillbirths. Clinical features include megalocephaly, short limbs, prominent forehead, thoracolumbar kyphosis and mid-face hypoplasia. Complications like dental malocclusion, hydrocephalus and repeated otitis media can be observed. The risk of death in infancy is increased due to the likelihood of compression of the spinal cord with or without upper airway obstruction.
The occurrence rate of achondroplasia in the children of fathers over 50 years of age is 1 in 1,875, compared to 1 in 15,000 in the general population .
Children with achondroplasia often have less muscle tone; because of this it is common for them to have delayed walking and motor skills. It is also common for children to have bowed legs, scoliosis, lordosis, arthritis, issues with joint flexibility, breathing problems, ear infections, and crowded teeth.
Achondroplasia is caused by a mutation in fibroblast growth factor receptor 3 ( FGFR3) gene. This gene is mainly responsible for making the protein, fibroblast growth factor receptor 3. This protein contributes to the production of collagen and other structural components in tissues and bones.
Those affected have an average adult height of 131 centimetres (4 ft 4 in) for males and 123 centimetres (4 ft) for females. Other features include an enlarged head and prominent forehead. Complications can include sleep apnea or recurrent ear infections. The disorder does not generally affect intelligence.
Pregnancy in women with achondroplasia is considered higher risk. Women with achondroplasia generally have their babies delivered through C-sections to prevent complications that could occur with a natural birth.
There is no known cure for achondroplasia even though the cause of the mutation in the growth factor receptor has been found. Although used by those without achondroplasia to aid in growth, human growth hormone does not help people with achondroplasia, which involve a different hormonal pathway. Usually, the best results appear within the first and second year of therapy. After the second year of growth hormone therapy, beneficial bone growth decreases, so the therapy is not a satisfactory long-term treatment.